## CHD: Church & Dwight Company, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.8% below STRENGTH zone (4.0-10.0%); PEG 1.95 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($81.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Westwood Holdings Group Inc. Has $79.86 Million Stock Holdings in Church & Dwight Co., Inc. $CHD**
- Source: MarketBeat | 20251214T142604 | Neutral | Relevance: 100%
- Westwood Holdings Group Inc. reduced its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 6.7% in Q2, holding 830,875 shares valued at approximately $79.86 million. Church & Dwight recently beat Q3 earnings estimates, set Q4 and FY2025 guidance, and declared a quarterly dividend. Analyst sentiment is mixed, with an average target price of $99.22.

**2. Balyasny Asset Management L.P. Purchases 123,853 Shares of Church & Dwight Co., Inc. $CHD**
- Source: MarketBeat | 20251213T110740 | Somewhat-Bullish | Relevance: 100%
- Balyasny Asset Management L.P. increased its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 10.5% in the second quarter, acquiring an additional 123,853 shares and bringing its total holdings to over 1.3 million shares worth approximately $125 million. Church & Dwight recently surpassed Q3 earnings expectations with an EPS of $0.81 and revenue of $1.59 billion, and it has set guidance for Q4 2025 and full-year 2025. The company also pays a quarterly dividend of $0.295, offering an annualized yield of 1.4%, while analysts maintain a consensus "Hold" rating with an average target price of $99.22.

**3. Church & Dwight to sell vitamin gummy businesses**
- Source: MSN | 20251211T160809 | Neutral | Relevance: 100%
- Church & Dwight, known for brands like Arm & Hammer and OxiClean, has announced its intention to sell five of its vitamin gummy businesses. This move is part of a strategic portfolio realignment to focus on core brands.

**4. Renewed Brand Focus Could Support Church & Dwight’s (CHD) EPS Growth, Says Argus**
- Source: Insider Monkey | 20251211T021600 | Somewhat-Bullish | Relevance: 100%
- Argus maintained a Buy rating on Church & Dwight Co., Inc. (CHD) but lowered its price target to $102 from $110, citing broader weakness in Consumer Goods. However, the firm believes Church & Dwight's renewed focus on leading brands will help capture market share and support an expected 8% annual EPS growth. In Q3 2025, CHD reported revenue of $1.6 billion, surpassing estimates, driven by balanced value, innovation, and strategic acquisitions like TOUCHLAND.

**5. Church & Dwight offloads VitaFusion and L’il Critters to focus on ‘power brands’**
- Source: Cosmetics Business | 20251210T114914 | Somewhat-Bearish | Relevance: 100%
- Church & Dwight has sold its vitamin brands VitaFusion and L’il Critters to Piping Rock Health Products following a strategic review. This divestiture is part of Church & Dwight's strategy to streamline its portfolio and focus on its remaining "power brands." The deal includes trademarks, licenses, and manufacturing facilities, and is expected to be completed by year-end, resulting in a one-off impairment charge of $40m-$45m.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Deutsche Bank | $100 | $102 | -2% |
| 2025-12-04 | Argus Research | $102 | $110 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Deutsche Bank | main | Buy |
| 2025-12-04 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 15 ($0.03M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 10.8% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +5.5% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.95 elevated, pricing in significant growth expectations. Forward P/E 22.6x stretched relative to 7% growth. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.6B |
| Beta | 0.45 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.95 |
| Forward P/E | 22.6 |
| Current P/E | 24.2 |
| YoY Growth | 7.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.7% to 0.8% (+5.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.2pp (needs >4.0% for momentum thesis). MRS_5 at 3.1% confirms short-term momentum alignment. Below SMA200 (0.89x), long-term trend not supportive. RSI neutral at 51. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.76% (CS: 45) | Neutral |
| RSI_14 | 51.4 | Neutral |
| MACD Histogram | 0.15 | Bullish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 0.991x | Below |
| vs SMA200 | 0.892x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $84.61
- **Stop Loss:** $81.23 (4.0% risk)
- **Target:** $87.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 355
- **Position Value:** $30,036.55
- **Portfolio %:** 30.04%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*